Scholarlink

<p>Four bis(benzimidazole) derivatives featuring different linkers, imino methyl (Ambmz), pyridine (Pybmz), ethene (Etbmz), and phenyl (Phbmz), were synthesized and investigated for their anticancer potential against human breast cancer (MCF-7) cells. The nature of the linker was found to play a decisive role in modulating the biological activity of these compounds. Cytotoxicity assays showed that Etbmz exhibited the most pronounced growth-inhibitory effect, followed by Pybmz and Ambmz, whereas Phbmz exhibited prolonged anticancer activity as evident by the conony assay. Further to understand their mechanism of interaction with human DNA Topoisomerase I (hTopo I), the DFT calculations, molecular docking, and 200-ns molecular dynamics (MD) simulations were performed. The docking and MM-GBSA analyses revealed strong and stable binding affinities (ΔG_bind ≈ − 74 to − 77&#xa0;kcal/mol), mainly governed by van der Waals and electrostatic interactions. The strong correlation between the computational findings and experimental cytotoxicity highlights the importance of linker flexibility and electronic features in determining enzyme inhibition. Overall, Etbmz emerges as a promising lead compound for the design of new benzimidazole-based anticancer agents targeting hTopo I.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of anticancer activity of bis(benzimidazole) derivatives on MCF 7 cells and interaction with human DNA topoisomerase I

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月13日

查看全文
  • P. M. Mahitha,
  • Ankitha Suresh,
  • J. Jincy,
  • Navya Roby,
  • Bhisham Narayan Singh,
  • Jamelah S. Al-Otaibi,
  • Y. Sheena Mary,
  • Ajeetkumar Patil,
  • Naveen V. Kulkarni

摘要

Four bis(benzimidazole) derivatives featuring different linkers, imino methyl (Ambmz), pyridine (Pybmz), ethene (Etbmz), and phenyl (Phbmz), were synthesized and investigated for their anticancer potential against human breast cancer (MCF-7) cells. The nature of the linker was found to play a decisive role in modulating the biological activity of these compounds. Cytotoxicity assays showed that Etbmz exhibited the most pronounced growth-inhibitory effect, followed by Pybmz and Ambmz, whereas Phbmz exhibited prolonged anticancer activity as evident by the conony assay. Further to understand their mechanism of interaction with human DNA Topoisomerase I (hTopo I), the DFT calculations, molecular docking, and 200-ns molecular dynamics (MD) simulations were performed. The docking and MM-GBSA analyses revealed strong and stable binding affinities (ΔG_bind ≈ − 74 to − 77 kcal/mol), mainly governed by van der Waals and electrostatic interactions. The strong correlation between the computational findings and experimental cytotoxicity highlights the importance of linker flexibility and electronic features in determining enzyme inhibition. Overall, Etbmz emerges as a promising lead compound for the design of new benzimidazole-based anticancer agents targeting hTopo I.